FI

Fountainhead Investment Partners

North America, Texas, United States, San Antonio

Description

Fountainhead Investment Partners funds innovation in medical devices, multicellular biologic sciences, and regenerative medicine.

Investor Profile

Fountainhead Investment Partners has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical, Pharmaceutical.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fountainhead Investment Partners frequently co-invest with?

C-Bridge Capital
North America, New York, United States, New York
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
SC
North America, New York, United States, New York
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
OC
North America, California, United States, Redwood City
Co-Investments: 1

What are some of recent deals done by Fountainhead Investment Partners?

AffaMed Therapeutics

New City, New York, United States

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

Biotechnology
Series BMar 30, 2021
Amount Raised: $170,000,000
AmnioLife

Gainesville, Florida, United States

AmnioLife is a biotechnology company focused on the development and commercialization of a unique biologic suite of products.

BiotechnologyMedicalPharmaceutical
Series AJan 6, 2016
Amount Raised: $689,000